Jeffrey Laseter, MD
Interventional Pain Medicine · Flowood, MSNPI 1710095880
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $725 of the $816 with a category attached, or 88.9%. Stryker accounts for 88.9% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $725, more than ten times the $55 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in MS, where the typical reported total is $2,720.
Across 7 payments — averaging $116.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$725
- Medline Industries LP$27
- Nalu Medical, Inc.$22
- Nevro Corp.$22
- Si-bone, Inc.$20
What the payments were for
- Travel & lodging$72589%
- Food & beverage$9111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 2 | $725 |
| Medline Industries LP | 2 | $27 |
| Nalu Medical, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $22 |
| Si-bone, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$725
How this compares
$816 in reported general payments places this provider in the 20th percentile of 24 interventional pain medicine providers in Mississippi.
See all interventional pain medicine providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 337 | $3,329 |
| Fentanyl | 12 | $1,131 |
| Diclofenac Sodium | 44 | $1,049 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 62 | $855 |
| Morphine Sulfate ErMorphine Sulfate | 23 | $809 |
| Tizanidine Hcl | 109 | $549 |
| Celecoxib | 30 | $450 |
| Morphine Sulfate | 23 | $313 |
| Meloxicam | 64 | $290 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $275 |
| Oxycodone Hcl | 13 | $238 |
| Ketorolac Tromethamine | 11 | $176 |
| Ibuprofen | 15 | $165 |
| Baclofen | 24 | $133 |
| Methocarbamol | 20 | $125 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Flowood
- Leonel VanceMadison$21K
- Eric PearsonMeridian$19K
- Charles MartinMeridian$18K
- Matthew BlanchardGulfport$10K
- Kenneth StaggsMeridian$5K
- Madelyn CraigMadison$5K
- John LutzJackson$5K
- Michael SteuerSouthaven$4K
- Kelly ColemanVancleave$4K
- Carol HarrisMeridian$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.